Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
Eva Poveda, Vincent SorianoDepartment of Infectious Diseases, Hospital Carlos III, Madrid, SpainAbstract: Maraviroc is the first CCR5 antagonist approved for the treatment of HIV-1 infection. It specifically inhibits the replication of R5 viruses by blocking viral entry. HIV-1 tropism can be estimat...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-03-01
|
| Series: | HIV/AIDS : Research and Palliative Care |
| Online Access: | http://www.dovepress.com/optimizing-management-of-treatment-naiumlve-and-treatment-experienced--a4111 |